Related Experiment Video
Updated: Jun 4, 2026
08:11
Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction
Published on: August 25, 2017
Systemic Delivery of aTransgene in Intact Animals by a Retroviral Vector.
M J Katovich1, H W Wang, C H Gelband
1Department of Pharmacodynamics, University of Florida, Gainesville, FL.
Methods in Molecular Medicine
|February 19, 2011
Summary
Essential hypertension, a chronic cardiovascular disease affecting millions, involves sustained high blood pressure (BP). New treatments are needed because current daily medications don't cure hypertension and compliance is a major issue.
Area of Science:
- Cardiovascular Medicine
- Hypertension Research
Background:
- Essential hypertension is a widespread chronic cardiovascular disease impacting over 50 million Americans.
- Characterized by sustained elevated blood pressure (BP), it poses significant risks to major organs like the heart, kidneys, and brain if left untreated.
Purpose of the Study:
- To highlight the critical need for more effective therapeutic interventions for essential hypertension.
- To address the challenges in managing this asymptomatic disease, including treatment compliance and the lack of curative agents.
Main Methods:
- This abstract discusses the pathophysiology and consequences of essential hypertension.
- It reviews current treatment limitations, focusing on daily pharmacological management and the absence of a cure.
Main Results:
- Untreated hypertension leads to severe cardiovascular events such as myocardial infarction, heart failure, stroke, and renal failure.
- Current daily BP-controlling medications do not offer a cure and face compliance challenges.
Conclusions:
- There is a significant unmet need for novel and more effective therapeutic strategies to manage essential hypertension.
- Advanced interventions are required to mitigate the long-term cardiovascular sequelae and improve patient outcomes.
